Omidenepag Isopropyl 0.002% versus Latanoprost 0.005% in Open-Angle Glaucoma/Ocular Hypertension: The Randomized Phase III PEONY Trial
Wang T.H.; Aung T.; Lu D.-W.; George R.; Senthil S.; Lu F.; Odani-Kawabata N.; Park K.H.
View publication
-
Therapeutic Area
Glaucoma
-
Categories
Clinical development
-
Affiliations
Department of Ophthalmology, National Taiwan University Hospital, Taipei, Taiwan; Singapore Eye Research Institute, Singapore National Eye Centre, Singapore; Duke-NUS Medical School, Singapore; Department of Ophthalmology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore; Department of Ophthalmology, Tri-Service General Hospital, Taipei, Taiwan; Sankara Nethralaya, Chennai, India; VST Centre for Glaucoma Care, Kallam Anji Reddy Campus, Hyderabad, India; Santen Pharmaceuticals, Inc, Emeryville, CA, United States; Santen Pharmaceuticals, Ltd, Osaka, Japan; Department of Ophthalmology, Seoul National University, Seoul, South Korea